• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Has anyone made a claim on their common stock?









What is that clown of a President now doing since he ran your company into bankruptcy. He started it by firing the medical director for cause instead of gracefully letting him exit. that started the whole whistleblower process - just read the documents on line. Messed up stock opportunities for everyone yet he walked away with six figures for selling the technology.